Applied Cells Inc. Enters Collaborative Research Agreement for the Development of Rare Cell Isolation in Minimum Residual Disease

Detection of Disseminating Tumor Cells (DTCs) holds promise for the early detection of potential relapse.  The presence of bone marrow DTCs correlate with increased relapse risk, decreasing overall survival. Applied Cells, a commercial provider of cell preparation and isolation solutions for tumor biology research, today announced that it will further its research collaboration on rare […]

Applied Cells, Inc. announces Early Access Program for its MARS® Bar System, a revolutionary fully automated high-capacity closed system for cell processing.

Santa Clara – December 2, 2020 – Applied Cells, Inc., announced today that the company will unveil its MARS® Bar System, a revolutionary fully automated high-capacity closed system for cell processing, for Early Access Program. The MARS® Bar system enables a new generation of magnetic cell isolation technology for separation of large volume blood and […]

Applied Cells Announces Evaluation of Its New MARS Platform at The University of Pennsylvania

SANTA CLARA, Calif., Jan. 20, 2020 University of Pennsylvania (Penn) and Applied Cells Inc., a Santa Clara, California based biotechnology company, announced today that they have entered into a Collaborative Research Agreement to evaluate Applied Cells new generation cell isolation and sample preparation system, “MARS“, in cancer and immunology research at Penn. Applied Cells proprietary innovative MARS […]